Physicians Group Urges Acceptance Of Non-Validated Animal Test Alternatives
This article was originally published in The Rose Sheet
You may also be interested in...
A ban on cosmetic animal testing in the U.S. would challenge companies' ability to ensure product safety as required by the Federal Food, Drug and Cosmetic Act, particularly with respect to safety-assessment components that can't be readily or confidently addressed by alternative methods. Companies facing liability risks may choose to borrow safety data for their ingredients derived via animal testing in other sectors to meet non-cosmetic regulatory requirements, TSG Senior Regulatory Consultant Bob Stewart suggests.
At FDA’s June 2 public meeting to prepare for the eighth iteration of the International Cooperation on Cosmetics Regulation, the agency recapped accomplishments from ICCR-7 and outlined cosmetic regulatory topics to be addressed at ICCR-8. Allergens are up for discussion, as are trace materials.
Regulators from the US, Canada, Japan and the EU met in Tokyo July 8-10 for the seventh annual meeting of the International Cooperation on Cosmetics Regulation. The group agreed to recommend a 10-ppm limit on lead in cosmetic products.